REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,195 | -53.6% | 18,500 | 0.0% | 0.01% | -52.4% |
| Q2 2023 | $457,320 | -8.4% | 18,500 | +19.4% | 0.02% | -19.2% |
| Q1 2023 | $499,255 | +108.0% | 15,500 | +19.2% | 0.03% | +85.7% |
| Q4 2022 | $239,980 | -31.6% | 13,000 | 0.0% | 0.01% | -30.0% |
| Q3 2022 | $351,000 | +95.0% | 13,000 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $180,000 | -29.1% | 13,000 | 0.0% | 0.01% | -9.1% |
| Q1 2022 | $254,000 | +19.8% | 13,000 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $212,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |